UWO Researcher Develops HIV Vaccine

October 19, 2006

Dr. Yong Kang, of The University of Western Ontario's Schulich School of Medicine & Dentistry, has developed a pioneering HIV vaccine that is being readied for clinical trial. A major South Korean firm, Curocom, has committed $85 million and is opening Curocom Canada at UWO's Research Park. The vaccine could be available within three years to treat patients suffering from low-level HIV infection, although "it will not be a cure for those suffering from full-blown AIDS." There is hope that it may ultimately provide complete immunity to HIV, however. Toronto Star article